» Articles » PMID: 25068009

Mechanisms of Hepatic Ischemia-reperfusion Injury and Protective Effects of Nitric Oxide

Overview
Specialty Gastroenterology
Date 2014 Jul 29
PMID 25068009
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatic ischemia-reperfusion injury (IRI) is a pathophysiological event post liver surgery or transplantation and significantly influences the prognosis of liver function. The mechanisms of IRI remain unclear, and effective methods are lacking for the prevention and therapy of IRI. Several factors/pathways have been implicated in the hepatic IRI process, including anaerobic metabolism, mitochondria, oxidative stress, intracellular calcium overload, liver Kupffer cells and neutrophils, and cytokines and chemokines. The role of nitric oxide (NO) in protecting against liver IRI has recently been reported. NO has been found to attenuate liver IRI through various mechanisms including reducing hepatocellular apoptosis, decreasing oxidative stress and leukocyte adhesion, increasing microcirculatory flow, and enhancing mitochondrial function. The purpose of this review is to provide insights into the mechanisms of liver IRI, indicating the potential protective factors/pathways that may help to improve therapeutic regimens for controlling hepatic IRI during liver surgery, and the potential therapeutic role of NO in liver IRI.

Citing Articles

Mono-HOPE Versus Dual-HOPE in Liver Transplantation: A Propensity Score-Matched Evaluation of Early Graft Outcome.

Koch D, Tamai M, Schirren M, Drefs M, Jacobi S, Lange C Transpl Int. 2025; 38:13891.

PMID: 39974599 PMC: 11835512. DOI: 10.3389/ti.2025.13891.


Impact of Hypothermic Oxygenated Machine Perfusion on Immune Cell Clearance in Liver Transplantation: Enhancing Graft Function and Post-Transplant Outcomes.

Koch D, Schirren M, Jacobi S, Niess H, Renz B, Werner J J Clin Med. 2025; 14(1.

PMID: 39797210 PMC: 11721044. DOI: 10.3390/jcm14010127.


Dynamics of Ischemia/Reperfusion Injury Markers During Normothermic Liver Machine Perfusion.

Caballero-Marcos A, Rodriguez-Bachiller L, Baroja-Mazo A, Morales A, Fernandez-Caceres P, Fernandez-Martinez M Transplant Direct. 2024; 10(12):e1728.

PMID: 39553741 PMC: 11567704. DOI: 10.1097/TXD.0000000000001728.


Hepatic ischemia-reperfusion syndrome and its effect on the cardiovascular system: The role of treprostinil, a synthetic prostacyclin analog.

Mouratidou C, Pavlidis E, Katsanos G, Kotoulas S, Mouloudi E, Tsoulfas G World J Gastrointest Surg. 2023; 15(9):1858-1870.

PMID: 37901735 PMC: 10600776. DOI: 10.4240/wjgs.v15.i9.1858.


Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure.

Nelson V, Stumbras A, Palumbo R, Riesgraf S, Balboa M, Hannah Z Bioengineering (Basel). 2023; 10(10).

PMID: 37892931 PMC: 10604724. DOI: 10.3390/bioengineering10101201.


References
1.
Duranski M, Greer J, Dejam A, Jaganmohan S, Hogg N, Langston W . Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 2005; 115(5):1232-40. PMC: 1077170. DOI: 10.1172/JCI22493. View

2.
Siriussawakul A, Zaky A, Lang J . Role of nitric oxide in hepatic ischemia-reperfusion injury. World J Gastroenterol. 2010; 16(48):6079-86. PMC: 3012576. DOI: 10.3748/wjg.v16.i48.6079. View

3.
Miyake T, Yokoyama Y, Kokuryo T, Mizutani T, Imamura A, Nagino M . Endothelial nitric oxide synthase plays a main role in producing nitric oxide in the superacute phase of hepatic ischemia prior to the upregulation of inducible nitric oxide synthase. J Surg Res. 2013; 183(2):742-51. DOI: 10.1016/j.jss.2013.01.048. View

4.
Datta G, Fuller B, Davidson B . Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol. 2013; 19(11):1683-98. PMC: 3607745. DOI: 10.3748/wjg.v19.i11.1683. View

5.
McCord J . Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985; 312(3):159-63. DOI: 10.1056/NEJM198501173120305. View